These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 14026169)
41. The effect of different dose levels of zirconium on the excretion and distribution of plutonium and yttrium. SCHUBERT J; WHITE MR J Biol Chem; 1950 May; 184(1):191-6. PubMed ID: 15421988 [No Abstract] [Full Text] [Related]
42. [RESULTS OF RADIOTHERAPY OF SKIN DISEASES WITH STRONTIUM 90-YTTRIUM 90]. SEVIN W; DIETZ H Arch Klin Exp Dermatol; 1964 Jun; 219():506-9. PubMed ID: 14237694 [No Abstract] [Full Text] [Related]
43. [RESULTS OF HYPOPHYSECTOMY WITH RADIOACTIVE GOLD AND YTTRIUM 90]. WENSE G; ZAENGL A Bull Soc Int Chir; 1964; 23():81-6. PubMed ID: 14139420 [No Abstract] [Full Text] [Related]
44. RADIOLOGICAL PHYSICS. DETERMINATION OF THE ACTIVITY OF AN YTTRIUM-90 SOLUTION. NYO-2740-1. GROSS W; BELL WB ORO Rep; 1964 Jan; ():85-90. PubMed ID: 14150436 [No Abstract] [Full Text] [Related]
45. [Influence of some substances on the absorption of radioactive strontium by bone crystals. I]. Golutvina MM; Semochkina LS Nauchnye Doki Vyss Shkoly Biol Nauki; 1975; (8):47-50. PubMed ID: 810184 [No Abstract] [Full Text] [Related]
46. Plutonium excretion. Study following treatment with zirconium citrate and edathamil calciumdisodium. SANDERS SM Arch Environ Health; 1961 Apr; 2():474-83. PubMed ID: 13746161 [No Abstract] [Full Text] [Related]
48. [Influence of DTPA therapy on the incorporation of Y 90 originating from the decomposition of Sr 90]. Steinbach KH; Weber E; Giss M Strahlentherapie; 1970 Mar; 139(3):318-22. PubMed ID: 5506842 [No Abstract] [Full Text] [Related]
49. Pituitary ablation by yttrium-90 implants for diabetic retinopathy. FRASER R; JOPLIN GF; STEINER RE Diabetes; 1962; 11():482-3. PubMed ID: 13959343 [No Abstract] [Full Text] [Related]
50. EXPERIMENTAL COMPARISON OF DOSIMETRIC DATA FOR YTTRIUM OXIDE (Y90) RODS. ELMANHARAWY MS Int J Appl Radiat Isot; 1965 Apr; 16():217-20. PubMed ID: 14319332 [No Abstract] [Full Text] [Related]
51. [APROPOS OF SARCOMAS INDUCED BY YTTRIUM AT THE SITE OF INJECTION IN RATS]. GRAF B; LAFUMA J Bull Assoc Fr Etud Cancer; 1965; 52():55-62. PubMed ID: 14324859 [No Abstract] [Full Text] [Related]
52. Assay of skeletally deposited strontium-90 in humans by measurement of bremsstrahlung. Dudley RA; Haim AB Health Phys; 1968 May; 14(5):449-59. PubMed ID: 5652041 [No Abstract] [Full Text] [Related]
53. Metabolic alterations in tissues perfused with decalcifying agents. KALANT H; MIYATA R Biochem J; 1963 Feb; 86(2):336-44. PubMed ID: 14030266 [No Abstract] [Full Text] [Related]
54. The experimental determination of the dose distribution around yttrium-90 sources suitable for pitutatry implantation. JONES E; MALLARD JR; ELMANHARAWY MS Phys Med Biol; 1963 Apr; 8():59-73. PubMed ID: 13964703 [No Abstract] [Full Text] [Related]
55. [Removal of radionuclides from the body. (Effect of isotope dilution on the effectivity in the DTPA)]. Altenstetter F; Bohne F; Catsch A Strahlentherapie; 1966 Nov; 131(3):361-70. PubMed ID: 4872812 [No Abstract] [Full Text] [Related]
57. [INTRA-ARTERIAL APPLICATION OF LARGE PARTICLES OF YTTRIUM 90 FOR TREATMENT OF TUMORS]. NOLAN TR; GRADY ED Minerva Med; 1965 Jun; 56():2037-40. PubMed ID: 14325061 [No Abstract] [Full Text] [Related]
58. [On the kinetics of the accumulation and excretion of strontium-90]. Moskalev IuI; Buldakov LA Radiobiologiia; 1967; 7(3):381-4. PubMed ID: 5616322 [No Abstract] [Full Text] [Related]